세계의 동물용 의약품 시장 보고서(2025년)
Veterinary Medicine Global Market Report 2025
상품코드 : 1793380
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,471,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,354,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,236,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

동물용 의약품 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.6%를 나타내 445억 5,000만 달러로 성장할 전망입니다. 예측기간의 성장은 수의의료에 있어서의 개별화의료, 수의학 연구의 세계화, 수의의료에 있어서의 원격의료의 채용, 기후 변화의 영향, 인수 공통 감염증에의 대비 등에 기인하는 것으로 예측됩니다. 예측 기간의 세계 동향에는 예방 건강 관리에 대한 주력, 동물용 의약품의 발전, 생명 공학 및 바이오 의약품, 디지털 건강 기술, 동물용 의약품의 세계화, 지속 가능하고 윤리적인 실천, 규정 준수 및 안전 등이 포함됩니다.

향후 5년간의 성장률 7.6%라고 하는 예측은 전회의 예측으로부터 0.1%의 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 의약품 원료 및 완제품 수입과 관련된 관세는 비용을 증가시키고 공급 변동을 일으킬 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

반려동물 주인 증가는 동물용 의약품 시장 성장을 가속할 것으로 예측됩니다. 반려동물의 주인은 동물을 소유하거나 길들이고 그를 돌보거나 건강에 책임을 지는 개인입니다. 이 책임은 동물용 의약품 수요를 촉진하고 동물용 의약품 시장의 확대에 기여하고 있습니다. 예를 들어 미국에 본사를 둔 비정부 단체인 셰르터 동물군은 2023년에 2022년에 비해 개 입양 수가 10만 9,000마리 증가했다고 보고했으며 입양 비율의 추세가 양호하다는 것을 보여주었습니다. 그러나 2023년 개 입양 총수는 전년보다 10만 8,000마리 가까이 적었습니다. 그 결과, 반려동물 사육 인구 증가가 동물용 의약품 시장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Veterinary medicine is a branch of medicine dedicated to preventing, diagnosing, and treating diseases in animals. It is essential for ensuring the health and well-being of pets, livestock, and wildlife. Additionally, veterinary medicine contributes significantly to public health by managing zoonotic diseases.

The primary products within veterinary medicine include drugs, vaccines, and medical feed additives. Drugs are pharmacologically active substances administered to animals to address illness and enhance their health and growth. These medications are provided through oral, parental (injection), and topical (on the skin) routes of administration. They are distributed via diverse channels, including veterinary hospital pharmacies and retail veterinary pharmacies. These products cater to various end-users such as reference laboratories, point-of-care testing or in-house testing facilities, veterinary hospitals and clinics, among others. The animals benefiting from these medications span companion and livestock animals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The veterinary medicine market research report is one of a series of new reports from The Business Research Company that provides veterinary medicine market statistics, including veterinary medicine industry global market size, regional shares, competitors with a veterinary medicine market share, detailed veterinary medicine market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary medicine industry. This veterinary medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary medicine market size has grown strongly in recent years. It will grow from $31.08 billion in 2024 to $33.21 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to advancements in veterinary science, rising awareness of zoonotic diseases, focus on animal welfare, globalization of pet trade, specialization in veterinary care, increased spending on pet healthcare.

The veterinary medicine market size is expected to see strong growth in the next few years. It will grow to $44.55 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to personalized medicine in veterinary care, globalization of veterinary research, telehealth adoption in veterinary care, climate change impact, zoonotic disease preparedness. Major trends in the forecast period include focus on preventive healthcare, advancements in animal pharmaceuticals, biotechnology and biopharmaceuticals, digital health technologies, globalization of veterinary medicine, sustainable and ethical practices, regulatory compliance and safety.

The forecast of 7.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs on raw pharmaceutical ingredients and finished drug imports can increase veterinary medicine costs and create supply fluctuations. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising number of pet owners is expected to fuel the growth of the veterinary medicine market. Pet owners are individuals who own or adopt animals and are responsible for their care and health. This responsibility drives demand for veterinary drugs and contributes to the expansion of the veterinary medicine market. For example, in 2023, Shelter Animals Count, a US-based non-governmental organization, reported an increase of 109,000 dog adoptions compared to 2022, showing a positive trend in adoption rates. However, the total number of dogs adopted in 2023 remains nearly 108,000 lower than the previous year. As a result, the growing population of pet owners is driving the veterinary medicine market.

The increasing demand for pet insurance is expected to fuel the growth of the veterinary medicine market. Pet insurance, a form of financial protection, covers veterinary costs associated with pet care, aiding pet owners in managing healthcare expenses. Pet insurance encompasses diagnostics, treatments, surgeries, medications, and hospitalization-all essential components of veterinary medicine. In May 2023, the North American Pet Health Insurance Association (NAPHIA) reported a notable increase, with 5.36 million pets insured in North America in 2022, reflecting a 21.7% rise from the 4.4 million in 2021. This growing adoption of pet insurance is a significant driver for the veterinary medicine market.

Leading companies in the veterinary medicine market are introducing innovative products, such as ethno-veterinary medicines, to gain a competitive advantage. Ethno-veterinary medicines are derived from Ayurvedic formulations and are designed to treat animal diseases. For example, in August 2023, Milma, an Indian dairy company, launched ethno-veterinary medicines as low-cost alternatives to allopathic veterinary drugs. These medicines provide a cost-effective solution for animal healthcare, helping reduce veterinary expenses for farmers and offering a simple, affordable, and farmer-friendly tool for prevention and treatment.

Key players in the veterinary medicine market are forming strategic partnerships to enhance research and development efforts. Strategic partnerships involve leveraging each other's strengths and resources to achieve mutual benefits and success. For instance, in May 2023, ILC Therapeutics, a Scottish biotech company, partnered with Dechra Pharmaceuticals, a UK-based veterinary medicine group, to develop a treatment for canine atopic dermatitis, focusing on ILC's Caniferon product. This collaboration highlights the growing intersection between technology and animal healthcare, marking a significant advancement in veterinary medicine.

In September 2022, Zoetis, a US-based animal health company, acquired Jurox for an undisclosed sum. This acquisition aims to enhance Zoetis' portfolio of parasiticides and anti-infectives, broadening its range of animal health products and creating opportunities for further global expansion. Jurox, an Australian veterinary pharmaceutical manufacturer, specializes in providing veterinary medicines.

Major companies operating in the veterinary medicine market are Zoetis Inc., Merck & Co. Inc., Elanco Animal Health Incorporated, Dechra Pharmaceuticals PLC, Ceva Sante Animale, Virbac, Boehringer Ingelheim International GmbH, Kindred Biosciences Inc., Biogenesis Bago SA, Indian Immunologicals Limited, Neogen Corporation, Hester Biosciences Limited, Phibro Animal Health, Vetoquinol S.A., IDEXX Laboratories Inc., Heska Corporation, Henry Schein Animal Health, Patterson Companies Inc., Covetrus Inc., VetPartners, National Veterinary Associates, Pathway Vet Alliance, VetCor, PetVet Care Centers, BluePearl Veterinary Partners, Banfield Pet Hospital, VCA Animal Hospitals, Mars Veterinary Health

North America was the largest region in the veterinary medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the veterinary medicine market report during the forecast period. The regions covered in the veterinary medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary medicine market consists of sales of dicloxacillin, erythromycin, tetracycline, and retinoids, which are naturally occurring and synthetic compounds with vitamin A activity. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for veterinary medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Veterinary Medicine Market Characteristics

3. Veterinary Medicine Market Trends And Strategies

4. Veterinary Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Veterinary Medicine Growth Analysis And Strategic Analysis Framework

6. Veterinary Medicine Market Segmentation

7. Veterinary Medicine Market Regional And Country Analysis

8. Asia-Pacific Veterinary Medicine Market

9. China Veterinary Medicine Market

10. India Veterinary Medicine Market

11. Japan Veterinary Medicine Market

12. Australia Veterinary Medicine Market

13. Indonesia Veterinary Medicine Market

14. South Korea Veterinary Medicine Market

15. Western Europe Veterinary Medicine Market

16. UK Veterinary Medicine Market

17. Germany Veterinary Medicine Market

18. France Veterinary Medicine Market

19. Italy Veterinary Medicine Market

20. Spain Veterinary Medicine Market

21. Eastern Europe Veterinary Medicine Market

22. Russia Veterinary Medicine Market

23. North America Veterinary Medicine Market

24. USA Veterinary Medicine Market

25. Canada Veterinary Medicine Market

26. South America Veterinary Medicine Market

27. Brazil Veterinary Medicine Market

28. Middle East Veterinary Medicine Market

29. Africa Veterinary Medicine Market

30. Veterinary Medicine Market Competitive Landscape And Company Profiles

31. Veterinary Medicine Market Other Major And Innovative Companies

32. Global Veterinary Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Medicine Market

34. Recent Developments In The Veterinary Medicine Market

35. Veterinary Medicine Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기